CMS Reveals Limited Digital Health Policies in Final Medicare Rule


In a move that has drawn considerable attention just days before the 2024 presidential election, the Centers for Medicare & Medicaid Services (CMS) has released the final calendar year 2025 physician fee schedule (PFS) rule. This rule, which impacts digital therapeutics, telehealth, rural health clinics, and opioid treatment programs, underscores CMS’s limited authority in shaping digital health payment policies.
Digital Health Policies
CMS has finalized several digital health policies, as initially proposed in July’s draft rule. However, the offerings remain modest. New codes have been introduced for digital therapeutics, particularly aimed at mental healthcare. These changes mainly involve redefining existing codes to distinguish them from remote therapeutic monitoring codes. CMS’s authority in this area is limited, prompting a call for congressional action to create a new benefit category for digital therapeutics.
Telehealth Policies
With the expiration of Medicare telehealth flexibilities looming at the end of 2024, CMS has highlighted the necessity for Congress to extend key telehealth waivers. These waivers have significantly expanded telehealth services since 2020. Permanent coverage for audio-only visits and direct supervision via telehealth has been confirmed, yet geographical and origin site restrictions continue to pose challenges. For further details, you can refer to the original article.
Rural Health Clinics and Federally Qualified Health Centers
CMS has been striving to achieve payment parity for telehealth services compared to in-person services in rural health clinics and federally qualified health centers. While a special payment rate is applied for telehealth, CMS has opted to retain its current payment methodology for now, though reforms may be considered in the future.
Opioid Treatment Programs
The rule acknowledges the importance of telehealth in opioid treatment programs, especially for older Medicare beneficiaries who rely heavily on audio-only services. CMS will allow telehealth usage for periodic assessments, marking a step forward in addressing opioid use disorder through digital means.
For a comprehensive understanding of the finalized rule and its implications, visit the CMS Federal Register.

Conclusion


While CMS has made some progress, the agency emphasizes the need for congressional action to broaden and secure these developments. The future of digital health policies remains uncertain, with much depending on legislative support.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Telehealth: Bridging the Gap in Healthcare Access

Telehealth has emerged as a vital tool in providing equitable healthcare access by increasing the availability of specialists and reducing transportation barriers.

By |December 24, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments

Revolutionizing Liver Cancer Diagnosis: An Emerging Market Potential

Liver cancer continues to be a significant health challenge globally, ranking as one of the leading causes of cancer-related deaths.

By |December 24, 2024|Categories: Article, Healthcare, Market Analysis|Tags: , |0 Comments

World Cities Day 2024: A Global Movement Towards Sustainable Urban Futures

In the spirit of World Cities Day, celebrated on October 31st, cities worldwide are embracing the theme "Youth Leading Climate and Local Action for Cities." This theme underscores the pivotal role of young leaders in driving sustainable urban solutions, a movement gaining momentum through community-led initiatives and progressive policies.

The Road Ahead: Self-Driving Cars Reshape the Automotive Industry

"Goldman Sachs envisions a scenario where AV sales, particularly those with Level 3 automation or higher, could account for 60% of all light vehicle sales by 2040. Even in a less optimistic scenario, AVs are expected to comprise nearly 40% of new sales."

Semaglutide: A Promising Ally Against Alzheimer’s?

A groundbreaking study by researchers at Case Western Reserve School of Medicine reveals semaglutide, a common diabetes and weight-loss drug, may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes.

By |December 23, 2024|Categories: Article, Health, Research|Tags: |0 Comments

Revolutionizing Healthcare: The AI Transformation in Louisiana

In the heart of Louisiana, a digital revolution is underway, reshaping the landscape of healthcare diagnostics with the power of artificial intelligence (AI). AI is not just a tool but a transformative force, enhancing diagnostic accuracy, improving patient outcomes, and reducing costs.